{
  "meta": {
    "title": "15_Cell_Cycle_Specific_Cytotoxic_Drugs",
    "url": "https://brainandscalpel.vercel.app/15-cell-cycle-specific-cytotoxic-drugs-7a8a4660.html",
    "scrapedAt": "2025-11-30T06:59:42.867Z"
  },
  "questions": [
    {
      "id": 51705,
      "choices": [
        {
          "id": 210452,
          "text": "Cyclophosphamide"
        },
        {
          "id": 210453,
          "text": "Chloramphenicol"
        },
        {
          "id": 210454,
          "text": "Capecitabine"
        },
        {
          "id": 210455,
          "text": "Mitomycin-D"
        }
      ],
      "text": "Hand and foot syndrome is caused by which anticancer drug:",
      "unique_key": "Q9897706",
      "question_audio": null,
      "question_video": null,
      "map_id": 34535615,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Capecitabine An oral prodrug of 5-fluorouracil (5-FU), which is a well-known cause of hand-foot syndrome (HFS), also called palmar-plantar erythrodysesthesia (PPE). HFS is a dose-limiting dermatologic toxicity characterized by erythema, swelling, pain, desquamation, and blistering of the palms and soles. The exact mechanism of HFS is not fully understood, but it is believed to be due to drug accumulation in sweat glands and skin capillaries, leading to local inflammation and damage to epidermal cells. Capecitabine and continuous-infusion 5-FU are the most common culprits of HFS, making capecitabine the correct answer. Explanation of Incorrect Options: Option A: Cyclophosphamide (Incorrect) Cyclophosphamide is an alkylating agent used in various cancers, but it is not a known cause of hand-foot syndrome. Its main toxicities include hemorrhagic cystitis (due to acrolein metabolite), myelosuppression, and cardiotoxicity at high doses. Option B: Chloramphenicol (Incorrect) Chloramphenicol is an antibiotic, not an anticancer drug. It is primarily associated with bone marrow suppression (dose-dependent reversible and dose-independent aplastic anemia) and Gray baby syndrome, but it does not cause hand-foot syndrome. Option D: Mitomycin-D (Incorrect) Mitomycin-D (Mitomycin C) is an antitumor antibiotic that causes myelosuppression, hemolytic uremic syndrome (HUS), and interstitial lung disease, but it is not a common cause of hand-foot syndrome. It works by cross-linking DNA and inhibiting DNA synthesis, making it effective against certain cancers, but it does not lead to PPE.",
      "correct_choice_id": 210454,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52712171700318677/52712171700318677.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52712171700318677/52712171700318677.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51706,
      "choices": [
        {
          "id": 210456,
          "text": "Cyclophosphamide"
        },
        {
          "id": 210457,
          "text": "Chloramphenicol"
        },
        {
          "id": 210458,
          "text": "Cytarabine"
        },
        {
          "id": 210459,
          "text": "Irinotecan"
        }
      ],
      "text": "Cerebellar ataxia is caused by which anticancer drug:",
      "unique_key": "Q3588954",
      "question_audio": null,
      "question_video": null,
      "map_id": 34342712,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Cytarabine A pyrimidine analog and antimetabolite used primarily in the treatment of acute myeloid leukemia (AML) and other hematologic malignancies. One of its well-known dose-dependent toxicities is cerebellar ataxia, which manifests as dysarthria, nystagmus, dysmetria, and impaired coordination. This occurs due to direct neurotoxicity affecting the Purkinje cells of the cerebellum, leading to dysfunction in motor coordination. High-dose cytarabine (HiDAC) regimens, renal impairment, and older age increase the risk of cerebellar toxicity. Monitoring for early signs of ataxia is crucial, as symptoms may be irreversible in severe cases. Explanation of Incorrect Options: Option A: Cyclophosphamide (Incorrect) Cyclophosphamide is an alkylating agent used in various cancers, but it does not typically cause cerebellar ataxia. Its major toxicities include hemorrhagic cystitis (due to acrolein metabolite), myelosuppression, and cardiotoxicity at high doses. Neurologic effects are rare and usually involve encephalopathy rather than cerebellar ataxia. Option B: Chloramphenicol (Incorrect) Chloramphenicol is an antibiotic, not an anticancer drug. It is associated with bone marrow suppression (leading to aplastic anemia) and Gray baby syndrome, but it is not a known cause of cerebellar ataxia. Option D: Irinotecan (Incorrect) Irinotecan is a topoisomerase I inhibitor used in colorectal cancer treatment. Its primary toxicities include severe diarrhea (due to cholinergic effects and delayed secretory diarrhea) and myelosuppression, but it does not cause cerebellar ataxia. Neurologic effects are rare and usually mild if present.",
      "correct_choice_id": 210458,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45238541700318688/45238541700318688.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45238541700318688/45238541700318688.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51707,
      "choices": [
        {
          "id": 210460,
          "text": "Vincristine"
        },
        {
          "id": 210461,
          "text": "Cyclophosphamide"
        },
        {
          "id": 210462,
          "text": "Cytarabine"
        },
        {
          "id": 210463,
          "text": "Vinblastine"
        }
      ],
      "text": "Which anti-neoplastic drug is cell cycle specific and acts on S-phase:",
      "unique_key": "Q6387324",
      "question_audio": null,
      "question_video": null,
      "map_id": 34040945,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Cytarabine, Which is a cell cycle-specific anti-neoplastic drug that acts during the S-phase (DNA synthesis phase) of the cell cycle. Cytarabine is a pyrimidine analog that gets incorporated into DNA, leading to chain termination and inhibition of DNA polymerase. By selectively targeting rapidly dividing cells during the S-phase, cytarabine is highly effective in acute myeloid leukemia (AML) and other hematologic malignancies. Because it specifically disrupts DNA replication, it is most effective against cancers with high proliferative rates. Explanation of Incorrect Options: Option A: Vincristine (Incorrect) Vincristine is a vinca alkaloid that acts during the M-phase (mitosis) of the cell cycle, not the S-phase. It works by binding to tubulin and inhibiting microtubule polymerization, leading to mitotic arrest and apoptosis. It is primarily used in leukemias, lymphomas, and solid tumors but does not target DNA synthesis directly. Option B: Cyclophosphamide (Incorrect) Cyclophosphamide is an alkylating agent that is cell cycle-nonspecific (CCNS), meaning it can act at any stage of the cell cycle. It functions by cross-linking DNA strands, leading to apoptosis in rapidly dividing cells. It is widely used in solid tumors, lymphomas, and autoimmune diseases but does not specifically target the S-phase. Option D: Vinblastine (Incorrect) Like vincristine, vinblastine is a vinca alkaloid that disrupts microtubule formation during M-phase (mitosis), leading to cell cycle arrest. It is mainly used in Hodgkin’s lymphoma, testicular cancer, and Kaposi’s sarcoma, but it does not affect DNA synthesis in the S-phase.",
      "correct_choice_id": 210462,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75621321700318740/75621321700318740.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75621321700318740/75621321700318740.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51708,
      "choices": [
        {
          "id": 210464,
          "text": "Adriamycin, Bleomycin, Vincristine, Dacarbazine"
        },
        {
          "id": 210465,
          "text": "Adriamycin, Bleomycin, Vinblastine, Dacarbazine"
        },
        {
          "id": 210466,
          "text": "Actinomycin, BCNU, Vincristine, DTIC"
        },
        {
          "id": 210467,
          "text": "Actinomycin, Bleomycin, Vinblastine, Dacarbazine"
        }
      ],
      "text": "The combination chemotherapy used in Hodgkin’s Lymphoma:",
      "unique_key": "Q2773380",
      "question_audio": null,
      "question_video": null,
      "map_id": 34753514,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Adriamycin (Doxorubicin) Bleomycin, Vinblastine, Dacarbazine (ABVD), which is the standard first-line chemotherapy regimen for Hodgkin’s Lymphoma. ABVD is preferred due to its high efficacy and lower long-term toxicity compared to older regimens like MOPP (Mechlorethamine, Oncovin, Procarbazine, and Prednisone). Each component of ABVD plays a crucial role: Adriamycin (Doxorubicin): A topoisomerase II inhibitor that intercalates into DNA, preventing replication and causing free radical-mediated DNA damage. Bleomycin: Induces DNA strand breaks through oxidative damage, primarily affecting the G2 phase of the cell cycle. Vinblastine: A microtubule inhibitor that disrupts mitotic spindle formation, leading to cell cycle arrest in the M-phase. Dacarbazine: A DNA alkylating agent that interferes with DNA replication, leading to apoptosis of cancer cells. Explanation of Incorrect Options: Option A: Adriamycin, Bleomycin, Vincristine, Dacarbazine (Incorrect) This combination is incorrect because it includes vincristine instead of vinblastine. While vincristine is a vinca alkaloid like vinblastine, it is used in other lymphomas (e.g., non-Hodgkin’s lymphoma and part of CHOP regimen) but not in standard ABVD therapy for Hodgkin’s lymphoma. Option C: Actinomycin, BCNU, Vincristine, DTIC (Incorrect) Actinomycin D (Dactinomycin) is not a standard drug in Hodgkin’s lymphoma treatment; it is mainly used in pediatric cancers like Wilms tumor and Ewing sarcoma. BCNU (Carmustine) is a nitrosourea alkylating agent, commonly used in brain tumors and multiple myeloma, but it is not a part of Hodgkin’s lymphoma treatment. DTIC (Dacarbazine) is correct, but the rest of the combination is incorrect for Hodgkin’s lymphoma. Option D: Actinomycin, Bleomycin, Vinblastine, Dacarbazine (Incorrect) This option is incorrect because it replaces Adriamycin (Doxorubicin) with Actinomycin D, which is not part of the ABVD regimen. Doxorubicin is a crucial drug in Hodgkin’s lymphoma treatment due to its strong cytotoxic effect, and replacing it with Actinomycin D reduces the efficacy of the regimen.",
      "correct_choice_id": 210465,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30063041700318762/30063041700318762.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30063041700318762/30063041700318762.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51709,
      "choices": [
        {
          "id": 210468,
          "text": "Vincristine"
        },
        {
          "id": 210469,
          "text": "Vinblastine"
        },
        {
          "id": 210470,
          "text": "Mitotane"
        },
        {
          "id": 210471,
          "text": "Methotrexate"
        }
      ],
      "text": "Medical adrenalectomy is seen with:",
      "unique_key": "Q5109485",
      "question_audio": null,
      "question_video": null,
      "map_id": 34881680,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Mitotane Chronic Myeloid Leukemia (CML) in its chronic phase is best treated with Imatinib (A), a first-generation tyrosine kinase inhibitor (TKI). Imatinib specifically targets the BCR-ABL fusion protein, which is responsible for the uncontrolled proliferation of myeloid cells in CML. By inhibiting the BCR-ABL tyrosine kinase, Imatinib effectively reduces the abnormal clonal expansion of leukemic cells, leading to significant hematologic and cytogenetic remission. It has revolutionized CML treatment and is considered the first-line therapy due to its high efficacy, tolerability, and ability to induce long-term remission. Incorrect Options: (B) Hydroxyurea: This drug is a cytoreductive agent that can be used to temporarily lower white blood cell (WBC) counts in CML patients. However, it does not target the underlying BCR-ABL fusion protein and does not provide long-term disease control. It is sometimes used in the initial management of very high leukocyte counts before starting Imatinib but is not a definitive treatment. (C) Interferon: Previously used in the treatment of CML before the advent of TKIs, interferon-alpha helped achieve partial cytogenetic responses but had limited efficacy and significant side effects. It has been largely replaced by Imatinib and other TKIs as a more effective and better-tolerated therapy. (D) Cytarabine: A chemotherapeutic agent that inhibits DNA synthesis, Cytarabine was historically used in combination with interferon in CML treatment. However, it lacks specificity for BCR-ABL, making it much less effective than Imatinib. It is now mainly used in the treatment of acute leukemias rather than CML.",
      "correct_choice_id": 210470,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46317401700318822/46317401700318822.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46317401700318822/46317401700318822.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51710,
      "choices": [
        {
          "id": 210472,
          "text": "Leucovorin"
        },
        {
          "id": 210473,
          "text": "Mannitol"
        },
        {
          "id": 210474,
          "text": "Mesna"
        },
        {
          "id": 210475,
          "text": "Dexrazoxane"
        }
      ],
      "text": "Which drug is given to prevent hemorrhagic cystitis?",
      "unique_key": "Q3205949",
      "question_audio": null,
      "question_video": null,
      "map_id": 34842352,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Mesna. Mesna (2-mercaptoethane sulfonate) is used to prevent hemorrhagic cystitis, a serious adverse effect caused by the urotoxic metabolites of cyclophosphamide and ifosfamide. These alkylating agents are metabolized in the liver into acrolein, a toxic compound that accumulates in the bladder and damages the urothelium, leading to inflammation and bleeding. Mesna works by binding to acrolein and neutralizing its toxic effects, thus protecting the bladder mucosa from injury. It is always administered concomitantly with high-dose cyclophosphamide or ifosfamide to reduce the risk of hemorrhagic cystitis. Incorrect Options: (A) Leucovorin: This is a reduced folate used to rescue normal cells from the toxic effects of methotrexate by replenishing folate stores. It does not neutralize acrolein or prevent hemorrhagic cystitis. (B) Mannitol: Mannitol is an osmotic diuretic used to promote diuresis and reduce intracranial pressure. While increased urine flow might help flush out some toxins, it does not specifically neutralize acrolein and is not the primary agent for preventing hemorrhagic cystitis. (D) Dexrazoxane: Dexrazoxane is a cardioprotective agent used to reduce anthracycline-induced cardiotoxicity, particularly with doxorubicin. It acts by chelating iron and reducing oxidative damage in cardiac tissues but has no role in preventing hemorrhagic cystitis.",
      "correct_choice_id": 210474,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78322471700318834/78322471700318834.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78322471700318834/78322471700318834.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51711,
      "choices": [
        {
          "id": 210476,
          "text": "Busulfan"
        },
        {
          "id": 210477,
          "text": "Bleomycin"
        },
        {
          "id": 210478,
          "text": "Bortezomib"
        },
        {
          "id": 210479,
          "text": "Benralizumab"
        }
      ],
      "text": "Which drug can cause flagellate hyperpigmention?",
      "unique_key": "Q9102759",
      "question_audio": null,
      "question_video": null,
      "map_id": 34947597,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Bleomycin. Bleomycin, an antitumor antibiotic, is known to cause flagellate hyperpigmentation, a distinctive skin reaction characterized by linear, streak-like, or whiplash-shaped dark patches. This occurs due to bleomycin-induced inflammation and toxicity in the skin, leading to post-inflammatory hyperpigmentation. The exact mechanism is not fully understood but is believed to involve bleomycin’s effects on melanocytes and local inflammatory responses. This side effect is most commonly seen in patients receiving high cumulative doses of bleomycin, and the pigmentation may persist for months even after discontinuation of the drug. Incorrect Options: (A) Busulfan: Busulfan is an alkylating agent used in conditioning regimens before bone marrow transplantation. It is known to cause skin hyperpigmentation, often described as \"busulfan tan,\" but it does not produce the characteristic flagellate (streak-like) pattern seen with bleomycin. (C) Bortezomib: Bortezomib is a proteasome inhibitor used to treat multiple myeloma and mantle cell lymphoma. It is associated with peripheral neuropathy and thrombocytopenia but does not typically cause hyperpigmentation or skin changes resembling flagellate pigmentation. (D) Benralizumab: Benralizumab is an anti-IL-5 receptor monoclonal antibody used to treat eosinophilic asthma. It is not known to cause any pigmentation disorders or dermatological side effects like flagellate hyperpigmentation.",
      "correct_choice_id": 210477,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33226751700318880/33226751700318880.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/33226751700318880/33226751700318880.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51712,
      "choices": [
        {
          "id": 210480,
          "text": "Mathotrexate"
        },
        {
          "id": 210481,
          "text": "5Flurouracil"
        },
        {
          "id": 210482,
          "text": "Gemcitabine"
        },
        {
          "id": 210483,
          "text": "Hydroxyurea"
        }
      ],
      "text": "Leucovorin can enhance the effect of which anticancer drug?",
      "unique_key": "Q3365946",
      "question_audio": null,
      "question_video": null,
      "map_id": 34216831,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) 5-Fluorouracil (5-FU). Leucovorin, also known as folinic acid, enhances the cytotoxic effect of 5-Fluorouracil (5-FU) by stabilizing the binding of 5-FU’s active metabolite (FdUMP) to thymidylate synthase (TS). This prolonged inhibition of thymidylate synthase leads to increased disruption of DNA synthesis, thereby amplifying the anticancer effects of 5-FU. This combination is commonly used in the treatment of colorectal cancer and other solid tumors to maximize therapeutic efficacy. Incorrect Options: (A) Methotrexate: Leucovorin is used as a rescue agent for high-dose methotrexate therapy, not to enhance its effects. Methotrexate inhibits dihydrofolate reductase (DHFR), leading to folate depletion and cytotoxicity. Leucovorin helps replenish folate levels in normal cells, reducing methotrexate toxicity while maintaining its anticancer action. Thus, leucovorin is given after high-dose methotrexate to rescue normal tissues, not to potentiate its effect. (C) Gemcitabine: Gemcitabine is a nucleoside analog that inhibits DNA synthesis by incorporating itself into DNA strands, leading to chain termination. It does not rely on folate metabolism, and leucovorin does not enhance its activity. (D) Hydroxyurea: Hydroxyurea inhibits ribonucleotide reductase, reducing deoxynucleotide synthesis and thereby impairing DNA replication. It is used in conditions like chronic myeloid leukemia (CML) and sickle cell disease, but leucovorin has no role in increasing its effectiveness.",
      "correct_choice_id": 210481,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41206961700318899/41206961700318899.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41206961700318899/41206961700318899.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51713,
      "choices": [
        {
          "id": 210484,
          "text": "Mutation of DHFR gene"
        },
        {
          "id": 210485,
          "text": "Defective of thymidylate kinase"
        },
        {
          "id": 210486,
          "text": "Defective of thymidylate synthase"
        },
        {
          "id": 210487,
          "text": "Over production of DHFRase enzyme"
        }
      ],
      "text": "A person taking Methotrexate after 3 weeks the effect of methotrexate decreases. This is most probably due to?",
      "unique_key": "Q7270685",
      "question_audio": null,
      "question_video": null,
      "map_id": 34287539,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Overproduction of DHFR enzyme. Methotrexate (MTX) is an antifolate drug that inhibits dihydrofolate reductase (DHFR), an enzyme essential for DNA synthesis and cell replication. DHFR converts dihydrofolate (DHF) to tetrahydrofolate (THF), which is required for the synthesis of purines and thymidylate. Over time, cancer cells can develop resistance to methotrexate by upregulating the production of DHFR enzyme. This compensatory overproduction allows the cells to bypass the inhibitory effect of methotrexate, leading to decreased drug efficacy after a few weeks of treatment. This is a well-known mechanism of methotrexate resistance in cancer therapy. Incorrect Options: (A) Mutation of DHFR gene: While mutations in the DHFR gene can contribute to methotrexate resistance, they are less common than the overproduction of DHFR. Most resistance mechanisms involve gene amplification rather than direct mutations that alter DHFR function. (B) Defective thymidylate kinase: Thymidylate kinase is involved in phosphorylating thymidine monophosphate (dTMP) to thymidine diphosphate (dTDP). It is not directly involved in methotrexate resistance. Methotrexate primarily targets DHFR, not thymidylate kinase, making this option incorrect. (C) Defective thymidylate synthase: Thymidylate synthase (TS) is another enzyme involved in DNA synthesis, catalyzing the conversion of dUMP to dTMP. While TS inhibition is an important target for 5-fluorouracil (5-FU), it is not the primary mechanism of methotrexate resistance.",
      "correct_choice_id": 210487,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/4556001700319064/4556001700319064.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/4556001700319064/4556001700319064.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51714,
      "choices": [
        {
          "id": 210488,
          "text": "Alkylating DNA, causing cross-links between parallel DNA strands"
        },
        {
          "id": 210489,
          "text": "Blocking microtubular assembly and mitosis during M-phase"
        },
        {
          "id": 210490,
          "text": "Inhibiting topoisomerase, preventing repair of DNA strand breaks"
        },
        {
          "id": 210491,
          "text": "Intercalating in DNA strands, there by preventing DNA replication by mRNA"
        }
      ],
      "text": "Which of the following is the main mechanism by which the mechlorethamine exerts its anticancer effect?",
      "unique_key": "Q6264020",
      "question_audio": null,
      "question_video": null,
      "map_id": 34863155,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Option A: Mechlorethamine, like cyclophosphamide,is an alkylating agent. They are called bifunctional alkylating agents because they can covalently bind to DNA in two places (“nucleophilic attack”), thereby forming cross-links between two adjacent strands or between two bases in one strand. This ultimately disrupts DNA and RNA synthesis or may cause strand breakage Option B: .Vincristine and the other vinca alkaloids bind to tubulin and impair microtubular assembly, preventing mitosis (M-phase-specific). The toxin (e.g., paclitaxel) impairs mitosis, but by stabilizing assembled microtubules rather than by exerting a vinca alkaloid-like inhibition of microtubular assembly Option C: Bleomycin, dactinomycin, and doxorubicin are drugs that intercalate in DNA strands. Thus, the altered DNA no longer serves as an adequately precise template for eventual synthesis of more functional DNA and RNA. They are classified as antitumor antibiotics. Option D: Etoposide and topotecan are examples of drugs that inhibit topoisomerase II. The consequence is inhibited ability of affected cells to repair DNA strand breaks. This stops the cell cycle in G2 phase",
      "correct_choice_id": 210488,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/18370041700319080/18370041700319080.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/18370041700319080/18370041700319080.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51715,
      "choices": [
        {
          "id": 210492,
          "text": "Water retention"
        },
        {
          "id": 210493,
          "text": "Neutropenia"
        },
        {
          "id": 210494,
          "text": "Peripheral neuropathy"
        },
        {
          "id": 210495,
          "text": "Alopecia"
        }
      ],
      "text": "Which of the following is the not adverse response to occur as a result of the vincristine?",
      "unique_key": "Q9158512",
      "question_audio": null,
      "question_video": null,
      "map_id": 34670888,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Vincristine is one of relatively few cytotoxic anticancer drugs that does not cause bone marrow suppression as its main toxicity. Rather, it causes neuropathies involving mainly motor nerves. Vincristine differs from the other two vinca alkaloids, vinblastine and vinorelbine, which do cause bone marrow suppression (and not neuropathies) as their main dose- limiting toxicity. Vincristine is Derived from the periwinkle plant. Its Mechanism of action isCell-cycle specific, blocking cells in M-phase. Binds specifically to tubulin, inhibiting the polymerization of microtubules. Ineffective chromosome segregation leads to apoptotic signals (programmed cell death) for both normal and malignant cells. Indication → ALL S/E B → Bone marrow suppression(rarely seen) R → Rashes (due to HSN Reaction, histamine realeased by Alkaloids ) A → Alopecia I → Inhibition of spindle (MOA) N → Nausea &Vomiting (M/C S/E), Neuropathy (Motor) ( Max : among anti CA drug ) S → SIADH(water retention)",
      "correct_choice_id": 210493,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45379861700319094/45379861700319094.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45379861700319094/45379861700319094.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51716,
      "choices": [
        {
          "id": 210496,
          "text": "Nephrotoxicity"
        },
        {
          "id": 210497,
          "text": "Myelosuppression"
        },
        {
          "id": 210498,
          "text": "Nausea & vomiting"
        },
        {
          "id": 210499,
          "text": "Neurotoxic"
        }
      ],
      "text": "Least common side effect of cisplatin is:",
      "unique_key": "Q1543915",
      "question_audio": null,
      "question_video": null,
      "map_id": 34894243,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Myelosuppression. Cisplatin is a platinum-based chemotherapeutic agent that works by forming DNA cross-links, leading to apoptosis in rapidly dividing cancer cells. While many chemotherapeutic agents cause myelosuppression as a primary side effect, cisplatin is unique in that it has relatively mild bone marrow suppression compared to other cytotoxic drugs. This makes myelosuppression the least common side effect of cisplatin. Incorrect Options: (A) Nephrotoxicity: Cisplatin-induced nephrotoxicity is a well-known and dose-limiting adverse effect. It damages the renal proximal tubules, leading to acute kidney injury (AKI). Hydration with saline and the use of diuretics (e.g., mannitol) are often recommended to prevent kidney damage. (C) Nausea & vomiting: Severe nausea and vomiting are among the most common side effects of cisplatin. It is one of the most emetogenic chemotherapy drugs, often requiring aggressive antiemetic therapy with 5-HT3 receptor antagonists (ondansetron), NK1 receptor antagonists (aprepitant), and corticosteroids. (D) Neurotoxicity: Cisplatin-induced neurotoxicity can manifest as peripheral neuropathy, with symptoms like paresthesia, numbness, and loss of proprioception. It is often dose-dependent and cumulative, making it a significant concern in long-term therapy.",
      "correct_choice_id": 210497,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13020371700319222/13020371700319222.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/13020371700319222/13020371700319222.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51717,
      "choices": [
        {
          "id": 210500,
          "text": "Bleomycin"
        },
        {
          "id": 210501,
          "text": "Amiodarone"
        },
        {
          "id": 210502,
          "text": "Chloramphenicol"
        },
        {
          "id": 210503,
          "text": "Methysergide"
        }
      ],
      "text": "Which of the following drug does not cause pulmonary fibrosis?",
      "unique_key": "Q3569473",
      "question_audio": null,
      "question_video": null,
      "map_id": 34511255,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Chloramphenicol. Chloramphenicol is a broad-spectrum antibiotic that is primarily associated with bone marrow suppression, aplastic anemia, and gray baby syndrome. It does not cause pulmonary fibrosis, making it the correct choice. The primary toxicities of chloramphenicol affect the hematopoietic system rather than the lungs. Incorrect Options: (A) Bleomycin: Bleomycin is a chemotherapeutic agent used primarily for testicular cancer, Hodgkin’s lymphoma, and squamous cell carcinomas. It is one of the most well-known causes of pulmonary fibrosis, as it induces oxidative damage in lung tissues, leading to progressive fibrosis. The risk is dose-dependent, especially at cumulative doses >400 units. (B) Amiodarone: Amiodarone is an antiarrhythmic drug (Class III) used for atrial fibrillation and ventricular arrhythmias. One of its severe adverse effects is pulmonary toxicity, which can lead to amiodarone-induced pulmonary fibrosis. This occurs due to its direct toxic effects on alveolar macrophages and lung parenchyma, leading to chronic interstitial lung disease. (D) Methysergide: Methysergide is an ergot derivative previously used for migraine prophylaxis. However, it has been associated with retroperitoneal fibrosis, cardiac fibrosis, and pulmonary fibrosis, limiting its use. The fibrotic changes are due to its long-term serotonergic effects on connective tissues.",
      "correct_choice_id": 210502,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56927791700319325/56927791700319325.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56927791700319325/56927791700319325.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51718,
      "choices": [
        {
          "id": 210504,
          "text": "It is obtained from E. coli"
        },
        {
          "id": 210505,
          "text": "It acts by enhancing the polymerization of β-tubulin"
        },
        {
          "id": 210506,
          "text": "It can cause bone marrow suppression"
        },
        {
          "id": 210507,
          "text": "It is used in ovarian and breast cancer"
        }
      ],
      "text": "All of the following statements about paclitaxel are true except:",
      "unique_key": "Q2556526",
      "question_audio": null,
      "question_video": null,
      "map_id": 34521869,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) It is obtained from E. coli. Paclitaxel is a natural product derived from the bark of the Pacific yew tree (Taxus brevifolia), not from Escherichia coli. It was initially extracted from this tree, but due to sustainability concerns, it is now synthesized semi-synthetically from precursors found in yew plant leaves. E. coli is commonly used in the recombinant production of some biologic drugs, but Paclitaxel is not one of them, making this statement incorrect. Incorrect Options: (B) It acts by enhancing the polymerization of β-tubulin: This statement is correct. Paclitaxel is a microtubule-stabilizing agent that binds to β-tubulin and promotes microtubule polymerization while preventing their depolymerization. This leads to cell cycle arrest at the M phase (mitotic arrest) and ultimately results in apoptosis of cancer cells. (C) It can cause bone marrow suppression: This is true. Myelosuppression, particularly neutropenia, is a common dose-limiting toxicity of Paclitaxel. Patients receiving the drug often require growth factor support (e.g., G-CSF) to prevent neutropenic complications. (D) It is used in ovarian and breast cancer: This is correct. Paclitaxel is widely used in the treatment of ovarian, breast, and lung cancers, as well as Kaposi’s sarcoma. It is often used in combination with platinum-based chemotherapy (e.g., cisplatin or carboplatin) for gynecological and lung malignancies.",
      "correct_choice_id": 210504,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28605671700319342/28605671700319342.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28605671700319342/28605671700319342.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51719,
      "choices": [
        {
          "id": 210508,
          "text": "Liver function tests"
        },
        {
          "id": 210509,
          "text": "Lung function test"
        },
        {
          "id": 210510,
          "text": "Eye examination"
        },
        {
          "id": 210511,
          "text": "Hemogram"
        }
      ],
      "text": "Which of the following parameters is not monitored in a patient on methotrexate therapy: (Recent NEET Pattern Q.)",
      "unique_key": "Q2122943",
      "question_audio": null,
      "question_video": null,
      "map_id": 34009550,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Eye examination. Methotrexate (MTX) is an antifolate chemotherapeutic and immunosuppressive drug used to treat cancers, rheumatoid arthritis, and other autoimmune diseases. While it has several systemic toxicities, ocular toxicity is not a common concern. Routine ophthalmic examinations are not required in patients taking methotrexate, making this the correct answer. Incorrect Options: (A) Liver function tests (LFTs): Methotrexate can cause hepatotoxicity, leading to elevated liver enzymes, fibrosis, and cirrhosis, particularly with long-term use. Regular monitoring of LFTs is essential to detect early liver damage and prevent progression to severe hepatic complications. (B) Lung function test: Methotrexate-induced pneumonitis is a rare but serious adverse effect. It can present as interstitial lung disease (ILD) with dry cough, dyspnea, and fever. Monitoring pulmonary function tests (PFTs) in symptomatic patients or those with pre-existing lung disease is recommended. (D) Hemogram: Methotrexate can cause bone marrow suppression, leading to leukopenia, anemia, and thrombocytopenia. Regular complete blood count (CBC) monitoring is necessary to detect cytopenias and prevent severe hematologic toxicity.",
      "correct_choice_id": 210510,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75100841700319374/75100841700319374.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75100841700319374/75100841700319374.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51720,
      "choices": [
        {
          "id": 210512,
          "text": "Type-I pneumocytes"
        },
        {
          "id": 210513,
          "text": "Type-II pneumocytes"
        },
        {
          "id": 210514,
          "text": "Endothelial cells"
        },
        {
          "id": 210515,
          "text": "Pulmonary alveolar macrophages"
        }
      ],
      "text": "Bleomycin toxicity affects which type of cells :",
      "unique_key": "Q3447546",
      "question_audio": null,
      "question_video": null,
      "map_id": 34887382,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Corret Answer (A) Type-I pneumocytes. Bleomycin-induced pulmonary toxicity primarily affects Type-I pneumocytes, leading to pulmonary fibrosis. Type-I pneumocytes are thin, delicate cells that line the alveoli and are responsible for gas exchange. These cells are particularly susceptible to oxidative damage because bleomycin generates free radicals, which cause DNA strand breaks, inflammation, and fibrosis. Since Type-I pneumocytes lack significant DNA repair mechanisms, they are highly vulnerable, leading to alveolar damage, fibrosis, and impaired oxygen exchange. Incorrect Options: (B) Type-II pneumocytes: While Type-II pneumocytes are also affected during bleomycin-induced lung injury, they are not the primary targets. These cells produce surfactant and play a role in alveolar repair and regeneration. Although they may undergo hyperplasia in response to lung injury, the direct cytotoxic effects of bleomycin are primarily on Type-I pneumocytes. (C) Endothelial cells: Bleomycin does have some effect on endothelial cells, particularly in pulmonary capillaries, contributing to vascular damage and inflammation. However, endothelial injury is secondary to alveolar damage, and fibrosis primarily results from pneumocyte destruction rather than endothelial cell loss. (D) Pulmonary alveolar macrophages: These immune cells play a role in inflammation and fibrosis by secreting cytokines in response to bleomycin-induced damage. However, they are not the direct targets of bleomycin toxicity; rather, they contribute to fibrotic progression by stimulating fibroblast proliferation.",
      "correct_choice_id": 210512,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/72358881700319401/72358881700319401.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/72358881700319401/72358881700319401.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51721,
      "choices": [
        {
          "id": 210516,
          "text": "Vincristine"
        },
        {
          "id": 210517,
          "text": "Vinblastine"
        },
        {
          "id": 210518,
          "text": "Actinomycin D"
        },
        {
          "id": 210519,
          "text": "Cyclophosphamide"
        }
      ],
      "text": "SIADH is caused by all except :",
      "unique_key": "Q7252182",
      "question_audio": null,
      "question_video": null,
      "map_id": 34781393,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Actinomycin D. Actinomycin D (Dactinomycin) is a cytotoxic antibiotic used mainly in the treatment of Wilms’ tumor, Ewing sarcoma, and rhabdomyosarcoma. It acts by binding to DNA and inhibiting RNA synthesis, leading to apoptosis in rapidly dividing cells. Unlike other options, Actinomycin D does not significantly affect ADH (antidiuretic hormone) regulation, making it the least likely to cause syndrome of inappropriate antidiuretic hormone secretion (SIADH). Incorrect Options: (A) Vincristine: Vincristine is a vinca alkaloid that inhibits microtubule formation, leading to mitotic arrest. It is strongly associated with SIADH, likely due to direct stimulation of ADH release from the posterior pituitary. This leads to hyponatremia and water retention, a characteristic feature of SIADH. (B) Vinblastine: Similar to vincristine, vinblastine is another vinca alkaloid that disrupts microtubule formation. While its association with SIADH is less pronounced compared to vincristine, it has still been reported to induce ADH secretion, leading to water retention and hyponatremia. (D) Cyclophosphamide: Cyclophosphamide is an alkylating agent used for various malignancies and autoimmune diseases. It can cause SIADH via a direct effect on the renal tubules, enhancing water reabsorption, in addition to stimulating ADH release from the pituitary. High-dose intravenous cyclophosphamide is particularly associated with significant water retention and hyponatremia.",
      "correct_choice_id": 210518,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10543941700319416/10543941700319416.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10543941700319416/10543941700319416.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51722,
      "choices": [
        {
          "id": 210520,
          "text": "Topoisomerase inhibition"
        },
        {
          "id": 210521,
          "text": "Increases the polymerization of tubulin"
        },
        {
          "id": 210522,
          "text": "Inhibits protein synthesis"
        },
        {
          "id": 210523,
          "text": "Alkylation of DNA"
        }
      ],
      "text": "Mechanism of action of paclitaxel is :",
      "unique_key": "Q1544907",
      "question_audio": null,
      "question_video": null,
      "map_id": 34623762,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Increases the polymerization of tubulin. Paclitaxel is a taxane class chemotherapeutic agent that exerts its effect by stabilizing microtubules. It enhances the polymerization of tubulin, preventing microtubule depolymerization and thereby arresting the cell cycle in the mitotic (M) phase. This disruption of normal microtubule dynamics leads to inhibition of cell division and apoptosis of rapidly dividing cancer cells. Paclitaxel is widely used in the treatment of breast cancer, ovarian cancer, lung cancer, and Kaposi's sarcoma. Incorrect Options: (A) Topoisomerase inhibition: Topoisomerase inhibitors, such as etoposide (Topoisomerase II inhibitor) and irinotecan (Topoisomerase I inhibitor), work by preventing the relaxation of supercoiled DNA, leading to DNA strand breaks and cell death. Paclitaxel does not affect topoisomerase enzymes; its mechanism is through microtubule stabilization. (C) Inhibits protein synthesis: Some chemotherapy drugs, such as cycloheximide or puromycin, work by blocking ribosomal function and inhibiting protein synthesis. Paclitaxel, however, does not interfere with ribosomes or protein synthesis but rather affects microtubules and mitosis. (D) Alkylation of DNA: Alkylating agents, such as cyclophosphamide and cisplatin, cause DNA cross-linking, leading to strand breaks and apoptosis. Paclitaxel does not interact directly with DNA; it targets microtubule stability instead.",
      "correct_choice_id": 210521,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/18693111700319426/18693111700319426.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/18693111700319426/18693111700319426.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51723,
      "choices": [
        {
          "id": 210524,
          "text": "Methotrexate"
        },
        {
          "id": 210525,
          "text": "6-Mercaptopurine"
        },
        {
          "id": 210526,
          "text": "Thio-TEPA"
        },
        {
          "id": 210527,
          "text": "Cytosine arabinoside"
        }
      ],
      "text": "Leucovorin is used to decrease the toxicity of :",
      "unique_key": "Q2435524",
      "question_audio": null,
      "question_video": null,
      "map_id": 34019209,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Methotrexate. Leucovorin (folinic acid) is used as a rescue therapy to reduce the toxicity of high-dose methotrexate (MTX) while preserving its antitumor efficacy. Methotrexate inhibits dihydrofolate reductase (DHFR), blocking folate metabolism and thereby preventing DNA synthesis in rapidly dividing cells. However, this effect is not selective for cancer cells and can lead to severe bone marrow suppression, mucositis, nephrotoxicity, and hepatotoxicity. Leucovorin bypasses the inhibited DHFR enzyme and provides a direct source of folate for normal cells, allowing them to continue DNA synthesis and recover from methotrexate-induced toxicity. It is especially crucial in high-dose MTX regimens used for osteosarcoma, leukemia, and lymphoma. Incorrect Options: (B) 6-Mercaptopurine (6-MP): 6-MP is a purine analog that inhibits DNA and RNA synthesis. Its toxicity is mainly increased when combined with allopurinol (which inhibits its metabolism by xanthine oxidase). Leucovorin has no role in reducing 6-MP toxicity. (C) Thio-TEPA: Thio-TEPA is an alkylating agent used in bladder cancer and bone marrow conditioning before transplantation. Its toxicity is mainly due to myelosuppression and mucositis, but leucovorin does not counteract its effects. (D) Cytosine arabinoside (Cytarabine): Cytarabine is a pyrimidine analog that inhibits DNA polymerase, mainly used in acute myeloid leukemia (AML) and lymphomas. Its dose-limiting toxicities include myelosuppression, cerebellar toxicity, and conjunctivitis. Leucovorin does not reduce cytarabine toxicity",
      "correct_choice_id": 210524,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59506581700319437/59506581700319437.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59506581700319437/59506581700319437.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51724,
      "choices": [
        {
          "id": 210528,
          "text": "Osteosarcoma"
        },
        {
          "id": 210529,
          "text": "Rhabdomyosarcoma"
        },
        {
          "id": 210530,
          "text": "Retinoblastoma"
        },
        {
          "id": 210531,
          "text": "Ewing’s sarcoma"
        }
      ],
      "text": "High dose methotrexate is used for the treatment of :",
      "unique_key": "Q2537404",
      "question_audio": null,
      "question_video": null,
      "map_id": 34223071,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Osteosarcoma. High-dose methotrexate (HDMTX) with leucovorin rescue is a key component of chemotherapy regimens for osteosarcoma, a highly aggressive primary bone malignancy. Methotrexate works by inhibiting dihydrofolate reductase (DHFR), blocking folate metabolism and thereby inhibiting DNA and RNA synthesis, leading to apoptosis of rapidly dividing cancer cells. HDMTX is particularly effective in pediatric and young adult osteosarcoma patients and is often combined with cisplatin, doxorubicin, and ifosfamide to improve survival rates. Leucovorin is administered after methotrexate to rescue normal cells from its toxic effects, reducing the risk of severe bone marrow suppression and nephrotoxicity. Incorrect Options: (B) Rhabdomyosarcoma: This is a soft tissue sarcoma arising from skeletal muscle progenitor cells, commonly treated with chemotherapy regimens such as VAC (Vincristine, Actinomycin D, Cyclophosphamide). Methotrexate is not a standard drug in rhabdomyosarcoma treatment. (C) Retinoblastoma: Retinoblastoma is a malignancy of the retina, typically treated with carboplatin, vincristine, and etoposide for systemic chemotherapy. Methotrexate is not used due to its limited penetration into the eye. (D) Ewing’s Sarcoma: This is a highly aggressive bone tumor, but it is primarily treated with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide (VDC/IE regimen). Methotrexate is not a part of Ewing’s sarcoma chemotherapy protocols.",
      "correct_choice_id": 210528,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7783741700319460/7783741700319460.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7783741700319460/7783741700319460.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51725,
      "choices": [
        {
          "id": 210532,
          "text": "Folinic acid enhances the action of methotrexate"
        },
        {
          "id": 210533,
          "text": "Methotrexate inhibits dihydrofolate reductase"
        },
        {
          "id": 210534,
          "text": "Non-proliferative cells are resistant to methotrexate"
        },
        {
          "id": 210535,
          "text": "Methotrexate is used in the treatment of psoriasis"
        }
      ],
      "text": "All of the following statements about methotrexate are correct except:",
      "unique_key": "Q1764913",
      "question_audio": null,
      "question_video": null,
      "map_id": 34312698,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Folinic acid enhances the action of methotrexate. This statement is incorrect because folinic acid (leucovorin) is actually used to rescue normal cells from methotrexate toxicity rather than enhance its action. Methotrexate is a folate antagonist that inhibits dihydrofolate reductase (DHFR), leading to depletion of tetrahydrofolate and subsequent inhibition of DNA synthesis. While methotrexate is toxic to both cancerous and normal cells, leucovorin provides a source of reduced folate, bypassing DHFR inhibition and rescuing normal cells from the drug's toxic effects. This is known as leucovorin rescue therapy, commonly used in high-dose methotrexate regimens. Incorrect Options: (B) Methotrexate inhibits dihydrofolate reductase – Correct Statement Methotrexate is an antimetabolite that inhibits dihydrofolate reductase (DHFR), preventing the conversion of dihydrofolate (DHF) to tetrahydrofolate (THF). This leads to disruption of purine and thymidylate synthesis, ultimately inhibiting DNA replication in rapidly dividing cells. (C) Non-proliferative cells are resistant to methotrexate – Correct Statement Methotrexate primarily targets rapidly dividing cells, such as cancer cells, bone marrow cells, and epithelial cells. Non-proliferating (quiescent) cells are relatively resistant to methotrexate because they do not require continuous DNA synthesis. This property contributes to its selectivity for cancer cells and rapidly dividing immune cells in autoimmune diseases. (D) Methotrexate is used in the treatment of psoriasis – Correct Statement Methotrexate is widely used for severe psoriasis and psoriatic arthritis due to its anti-proliferative and immunosuppressive effects. It reduces the excessive proliferation of keratinocytes in psoriasis and suppresses immune-mediated inflammation.",
      "correct_choice_id": 210532,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78024541700319494/78024541700319494.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/78024541700319494/78024541700319494.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51726,
      "choices": [
        {
          "id": 210536,
          "text": "Doxorubicin"
        },
        {
          "id": 210537,
          "text": "Irinotecan"
        },
        {
          "id": 210538,
          "text": "Etoposide"
        },
        {
          "id": 210539,
          "text": "Vincristine"
        }
      ],
      "text": "Which of the following drugs is topoisomerase 1 inhibitor:",
      "unique_key": "Q4582705",
      "question_audio": null,
      "question_video": null,
      "map_id": 34346033,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Irinotecan. Irinotecan is a topoisomerase I inhibitor, which means it prevents the re-ligation of single-stranded DNA breaks created by topoisomerase I during DNA replication. This leads to accumulation of DNA damage, ultimately causing apoptosis in rapidly dividing cancer cells. Irinotecan is primarily used in the treatment of colorectal cancer, often in combination with other chemotherapeutic agents like fluorouracil (5-FU). Incorrect Options: (A) Doxorubicin – Incorrect Doxorubicin is not a topoisomerase I inhibitor; instead, it is a topoisomerase II inhibitor. It works by intercalating into DNA and preventing topoisomerase II from resealing double-stranded breaks, leading to cytotoxic effects. It is used in breast cancer, leukemia, lymphoma, and sarcomas but is also known for causing cardiotoxicity. (C) Etoposide – Incorrect Etoposide is a topoisomerase II inhibitor, not a topoisomerase I inhibitor. It induces double-stranded DNA breaks by stabilizing the topoisomerase II-DNA complex, leading to cell cycle arrest and apoptosis. Etoposide is commonly used in lung cancer and testicular cancer. (D) Vincristine – Incorrect Vincristine is a microtubule inhibitor, not a topoisomerase inhibitor. It binds to β-tubulin, preventing microtubule polymerization, thereby arresting the cell cycle in metaphase (M-phase). It is used in leukemias, lymphomas, and neuroblastomas, and its most significant toxicity is peripheral neuropathy.",
      "correct_choice_id": 210537,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68429121700319528/68429121700319528.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68429121700319528/68429121700319528.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51727,
      "choices": [
        {
          "id": 210540,
          "text": "Cyclophosphamide"
        },
        {
          "id": 210541,
          "text": "Paclitaxel"
        },
        {
          "id": 210542,
          "text": "Methotrexate"
        },
        {
          "id": 210543,
          "text": "Vencristine"
        }
      ],
      "text": "Which of the following is an alkylating agent :",
      "unique_key": "Q4918632",
      "question_audio": null,
      "question_video": null,
      "map_id": 34172166,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Cyclophosphamide. Cyclophosphamide is an alkylating agent, meaning it works by adding alkyl groups to DNA, leading to cross-linking and strand breakage. This results in inhibition of DNA replication and transcription, ultimately leading to cell death. It is a nitrogen mustard derivative and is commonly used in the treatment of leukemia, lymphoma, breast cancer, and autoimmune diseases. Incorrect Options: (B) Paclitaxel – Incorrect Paclitaxel is not an alkylating agent; it is a microtubule inhibitor. It stabilizes microtubules, preventing their depolymerization, which leads to cell cycle arrest in the M phase (mitosis). It is commonly used in breast, ovarian, and lung cancers. (C) Methotrexate – Incorrect Methotrexate is an antimetabolite, not an alkylating agent. It inhibits dihydrofolate reductase (DHFR), leading to reduced DNA synthesis by depleting tetrahydrofolate (THF). It is used in cancers like leukemia, lymphoma, and osteosarcoma, as well as autoimmune diseases like rheumatoid arthritis. (D) Vincristine – Incorrect Vincristine is a microtubule inhibitor, not an alkylating agent. It binds to β-tubulin, preventing microtubule polymerization and causing cell cycle arrest in metaphase (M-phase). It is used in leukemias, lymphomas, and neuroblastomas and is known for causing peripheral neuropathy.",
      "correct_choice_id": 210540,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70281021700319538/70281021700319538.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70281021700319538/70281021700319538.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51728,
      "choices": [
        {
          "id": 210544,
          "text": "Gastrointestinal stromal tumors"
        },
        {
          "id": 210545,
          "text": "Receptor medicated neuroendocrine tumors"
        },
        {
          "id": 210546,
          "text": "Breast cancer"
        },
        {
          "id": 210547,
          "text": "Renal cell carcinoma"
        }
      ],
      "text": "Tyrosine kinase inhibitors are first line treatment in :",
      "unique_key": "Q4941077",
      "question_audio": null,
      "question_video": null,
      "map_id": 34285795,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Gastrointestinal stromal tumors (GISTs). Tyrosine kinase inhibitors (TKIs) like imatinib are the first-line treatment for GISTs, which are driven by mutations in the c-KIT (CD117) receptor tyrosine kinase or PDGFRA (platelet-derived growth factor receptor alpha). Imatinib specifically targets these mutated kinases, blocking their signaling pathways and effectively controlling tumor growth. It is particularly effective in KIT-positive GISTs, significantly improving progression-free survival and overall outcomes. Incorrect Options: (B) Receptor-mediated neuroendocrine tumors – Incorrect Neuroendocrine tumors (NETs) are generally treated with somatostatin analogs (e.g., octreotide, lanreotide) as first-line therapy. While some TKIs like sunitinib have shown efficacy in advanced or metastatic NETs, they are not the first-line treatment. (C) Breast cancer – Incorrect The primary treatment for breast cancer depends on the hormone receptor (HR) and HER2 status. Hormonal therapies (e.g., tamoxifen, aromatase inhibitors) are first-line for HR-positive breast cancer, while trastuzumab (a monoclonal antibody targeting HER2) is used for HER2-positive cases. TKIs like lapatinib are used in HER2-positive metastatic breast cancer but are not the first-line treatment. (D) Renal cell carcinoma – Incorrect While TKIs like sunitinib and pazopanib are used in renal cell carcinoma (RCC), the first-line treatment varies based on disease stage and risk group. In advanced RCC, immune checkpoint inhibitors (e.g., nivolumab + ipilimumab) or combination therapy with TKIs (e.g., axitinib + pembrolizumab) are preferred over TKIs alone. Therefore, TKIs are an important treatment but not the absolute first-line therapy in all RCC cases.",
      "correct_choice_id": 210544,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42026571700319678/42026571700319678.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42026571700319678/42026571700319678.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51729,
      "choices": [
        {
          "id": 210548,
          "text": "Letrozole"
        },
        {
          "id": 210549,
          "text": "Exemestane"
        },
        {
          "id": 210550,
          "text": "Taxanes"
        },
        {
          "id": 210551,
          "text": "Tamoxifen"
        }
      ],
      "text": "All the following are hormonal agents used against breast cancer except:",
      "unique_key": "Q5650441",
      "question_audio": null,
      "question_video": null,
      "map_id": 34148005,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Taxanes. Taxanes (such as paclitaxel and docetaxel) are not hormonal agents but rather microtubule-stabilizing agents used in chemotherapy for breast cancer. They work by promoting tubulin polymerization and inhibiting microtubule depolymerization, leading to cell cycle arrest and apoptosis. Taxanes are widely used in breast cancer treatment, especially in triple-negative breast cancer (TNBC) and HER2-positive breast cancer, but they do not act via hormonal mechanisms. Incorrect Options: (A) Letrozole – Incorrect Letrozole is a non-steroidal aromatase inhibitor that reduces estrogen production by inhibiting the aromatase enzyme. It is commonly used in postmenopausal women with estrogen receptor-positive (ER+) breast cancer. (B) Exemestane – Incorrect Exemestane is a steroidal aromatase inhibitor that irreversibly inhibits the aromatase enzyme, reducing estrogen levels. It is another key hormonal therapy for ER+ breast cancer in postmenopausal women. (D) Tamoxifen – Incorrect Tamoxifen is a selective estrogen receptor modulator (SERM) that acts as an estrogen antagonist in breast tissue while being an agonist in other tissues (such as bone and endometrium). It is widely used for both premenopausal and postmenopausal women with ER+ breast cancer.",
      "correct_choice_id": 210550,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63404751700319720/63404751700319720.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63404751700319720/63404751700319720.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51730,
      "choices": [
        {
          "id": 210552,
          "text": "Oral alkylating agent"
        },
        {
          "id": 210553,
          "text": "Antitumor antibiotic"
        },
        {
          "id": 210554,
          "text": "Antimetabolite"
        },
        {
          "id": 210555,
          "text": "Mitotic Spindle inhibitor"
        }
      ],
      "text": "Which group of anticancer drugs temozolomide belong to:",
      "unique_key": "Q7886400",
      "question_audio": null,
      "question_video": null,
      "map_id": 34589657,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Oral alkylating agent. Temozolomide (TMZ) is an oral alkylating agent used primarily for the treatment of glioblastoma multiforme (GBM) and anaplastic astrocytoma. It belongs to the imidazotetrazine class and acts by methylating DNA at the O6, N7, and N3 positions of guanine, leading to DNA damage and apoptosis. Its ability to cross the blood-brain barrier makes it particularly effective for brain tumors. Incorrect Options: (B) Antitumor antibiotic – Incorrect Antitumor antibiotics such as doxorubicin, actinomycin-D, and bleomycin work by intercalating DNA and generating free radicals that cause strand breaks. Temozolomide does not act via this mechanism, so it does not belong to this class. (C) Antimetabolite – Incorrect Antimetabolites like methotrexate, 5-FU, and cytarabine interfere with DNA and RNA synthesis by mimicking natural substrates. Temozolomide does not inhibit nucleotide metabolism but instead directly alkylates DNA, making it an alkylating agent rather than an antimetabolite. (D) Mitotic Spindle Inhibitor – Incorrect Mitotic spindle inhibitors such as vincristine, vinblastine, and paclitaxel prevent microtubule assembly or disassembly, disrupting mitosis. Temozolomide does not interfere with the mitotic spindle, so it does not fall into this category.",
      "correct_choice_id": 210552,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/14443921700319797/14443921700319797.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/14443921700319797/14443921700319797.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51731,
      "choices": [
        {
          "id": 210556,
          "text": "It is an alkaloid"
        },
        {
          "id": 210557,
          "text": "Its use is associated with neurotoxicity"
        },
        {
          "id": 210558,
          "text": "It does not cause alopecia"
        },
        {
          "id": 210559,
          "text": "It is a useful drug for induction of remission in acute lymphoblastic leukemia"
        }
      ],
      "text": "Which of the following statements is FALSE regarding vincristine :",
      "unique_key": "Q9564703",
      "question_audio": null,
      "question_video": null,
      "map_id": 34631915,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) It does not cause alopecia (False statement). Vincristine is a vinca alkaloid that disrupts microtubule formation by binding to tubulin, preventing mitotic spindle formation, which ultimately leads to cell cycle arrest in metaphase. It is well-known to cause alopecia as a side effect, making option C false. Alopecia occurs because chemotherapy targets rapidly dividing cells, including hair follicle cells, leading to hair loss. Incorrect Options (True Statements): (A) It is an alkaloid – True Vincristine is derived from the Madagascar periwinkle plant (Catharanthus roseus) and belongs to the vinca alkaloid class of chemotherapy agents. It is a natural plant-derived compound with a well-established role in cancer treatment. (B) Its use is associated with neurotoxicity – True One of the major dose-limiting toxicities of vincristine is neurotoxicity, which manifests as peripheral neuropathy, constipation (due to autonomic neuropathy), foot drop, and paresthesia. This occurs because vincristine disrupts microtubule-dependent axonal transport in neurons, leading to cumulative nerve damage. (D) It is a useful drug for induction of remission in acute lymphoblastic leukemia – True Vincristine is a key component of the chemotherapy regimen used in the treatment of acute lymphoblastic leukemia (ALL). It is part of induction therapy alongside corticosteroids, asparaginase, and anthracyclines.",
      "correct_choice_id": 210558,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/12281181700319839/12281181700319839.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/12281181700319839/12281181700319839.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51732,
      "choices": [
        {
          "id": 210560,
          "text": "Antimetabolite"
        },
        {
          "id": 210561,
          "text": "Anti-mitotic"
        },
        {
          "id": 210562,
          "text": "Topoisomerase inhibitor"
        },
        {
          "id": 210563,
          "text": "Direct DNA chelating agent"
        }
      ],
      "text": "Mechanism of action of 5-FU is :",
      "unique_key": "Q4477893",
      "question_audio": null,
      "question_video": null,
      "map_id": 34274397,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Antimetabolite. 5-Fluorouracil (5-FU) is an antimetabolite that exerts its anticancer effects by interfering with pyrimidine metabolism. It is a pyrimidine analog that gets converted intracellularly into active metabolites, such as fluorodeoxyuridine monophosphate (FdUMP), which inhibits thymidylate synthase (TS). This inhibition prevents the formation of thymidine, a crucial component for DNA synthesis, leading to DNA damage and cell death. Additionally, its incorporation into RNA disrupts RNA processing and function, further contributing to cytotoxicity. Incorrect Options (True Statements): (B) Anti-mitotic – Incorrect Anti-mitotic agents, such as vinca alkaloids (vincristine, vinblastine) and taxanes (paclitaxel, docetaxel), act by disrupting microtubule formation, leading to mitotic arrest. However, 5-FU does not target microtubules; instead, it affects DNA and RNA synthesis, making this answer incorrect. (C) Topoisomerase inhibitor – Incorrect Topoisomerase inhibitors, such as irinotecan (topoisomerase I inhibitor) and etoposide (topoisomerase II inhibitor), work by preventing DNA unwinding and replication. 5-FU does not inhibit topoisomerases, so this is an incorrect option. (D) Direct DNA chelating agent – Incorrect Direct DNA chelating agents, such as bleomycin, work by binding to DNA and generating free radicals, leading to DNA strand breaks. 5-FU does not function via direct DNA chelation, making this answer incorrect.",
      "correct_choice_id": 210560,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/32418211700319980/32418211700319980.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/32418211700319980/32418211700319980.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51733,
      "choices": [
        {
          "id": 210564,
          "text": "Cyclophosphamide"
        },
        {
          "id": 210565,
          "text": "Cisplatin"
        },
        {
          "id": 210566,
          "text": "Bleomycin"
        },
        {
          "id": 210567,
          "text": "Cytosine arabinoside"
        }
      ],
      "text": "Which of the following anti-neoplastic drugs SHOULD NOT be given by rapid IV infusion:",
      "unique_key": "Q5934467",
      "question_audio": null,
      "question_video": null,
      "map_id": 34661025,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Cisplatin. Cisplatin should not be administered by rapid IV infusion because of its severe nephrotoxicity, ototoxicity, and neurotoxicity. Rapid infusion can lead to high peak plasma concentrations, increasing the risk of acute kidney injury (AKI) due to proximal tubular damage. To minimize toxicity, cisplatin is administered slowly over several hours with aggressive pre- and post-hydration therapy using saline or mannitol diuresis to protect the kidneys. Incorrect Options (True Statements): (A) Cyclophosphamide – Incorrect Cyclophosphamide can be given by rapid IV infusion because it is a prodrug that requires metabolic activation in the liver to form its active metabolites. Its toxicity, such as hemorrhagic cystitis, is dose-dependent rather than infusion-rate dependent, and can be managed with MESNA (mercaptoethane sulfonate Na) and hydration. (C) Bleomycin – Incorrect Bleomycin is usually given slowly via IV push or continuous infusion to reduce the risk of pulmonary toxicity. However, it does not require prolonged infusion, unlike cisplatin. Rapid administration can cause hypotension and hypersensitivity reactions, but its primary toxicity (pulmonary fibrosis) is more related to cumulative dose rather than infusion rate. (D) Cytosine arabinoside (Cytarabine) – Incorrect Cytarabine is often given as a rapid IV bolus or continuous infusion because its cytotoxic effects depend on duration of exposure rather than peak plasma levels. High-dose cytarabine (HiDAC) therapy is used for treating acute myeloid leukemia (AML) but can cause cerebellar toxicity, myelosuppression, and conjunctivitis, which are dose-dependent rather than infusion rate-related.",
      "correct_choice_id": 210565,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51616311700319992/51616311700319992.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51616311700319992/51616311700319992.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51734,
      "choices": [
        {
          "id": 210568,
          "text": "Methotrexate"
        },
        {
          "id": 210569,
          "text": "5 Fluorouracil"
        },
        {
          "id": 210570,
          "text": "Gemcitabine"
        },
        {
          "id": 210571,
          "text": "Vincristine"
        }
      ],
      "text": "Which of the following is not an antimetabolite:",
      "unique_key": "Q9312604",
      "question_audio": null,
      "question_video": null,
      "map_id": 34913239,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Vincristine. Vincristine is not an antimetabolite; rather, it belongs to the vinca alkaloid class of chemotherapeutic agents. It acts by binding to tubulin and inhibiting microtubule polymerization, which disrupts mitotic spindle formation and leads to M-phase arrest in the cell cycle. Due to its mechanism of action, vincristine is classified as a mitotic inhibitor and is widely used in the treatment of leukemias, lymphomas, and solid tumors. Incorrect Options: (A) Methotrexate – Incorrect Methotrexate (MTX) is an antimetabolite that inhibits dihydrofolate reductase (DHFR), thereby blocking the conversion of dihydrofolate to tetrahydrofolate, which is essential for the synthesis of purines and thymidylate. This disrupts DNA and RNA synthesis, making it effective in treating leukemias, lymphomas, and solid tumors. (B) 5-Fluorouracil (5-FU) – Incorrect 5-Fluorouracil is a pyrimidine analog antimetabolite that inhibits thymidylate synthase, leading to a depletion of thymidine and subsequent inhibition of DNA synthesis. It is widely used for treating colorectal, breast, gastric, and pancreatic cancers. (C) Gemcitabine – Incorrect Gemcitabine is a deoxycytidine analog antimetabolite that incorporates into DNA and inhibits DNA polymerase and ribonucleotide reductase, disrupting DNA replication. It is commonly used in pancreatic, lung, and breast cancers.",
      "correct_choice_id": 210571,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69031081700320021/69031081700320021.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69031081700320021/69031081700320021.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51735,
      "choices": [
        {
          "id": 210572,
          "text": "5-α reductase inhibitor"
        },
        {
          "id": 210573,
          "text": "Phosphodiesterase inhibitor"
        },
        {
          "id": 210574,
          "text": "Alpha blocker"
        },
        {
          "id": 210575,
          "text": "Androgen receptor blocker"
        }
      ],
      "text": "Finasteride is a:",
      "unique_key": "Q6481616",
      "question_audio": null,
      "question_video": null,
      "map_id": 34593612,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) 5-alpha reductase inhibitor, which means it inhibits the enzyme 5-alpha reductase responsible for converting testosterone into dihydrotestosterone (DHT). DHT is a potent androgen that plays a crucial role in conditions like benign prostatic hyperplasia (BPH) and androgenic alopecia (male pattern baldness). By reducing DHT levels, finasteride helps shrink an enlarged prostate and slow hair loss progression. It is commonly used to treat BPH at a dose of 5 mg daily and male pattern baldness at a dose of 1 mg daily. The drug does not affect testosterone production but specifically lowers DHT-dependent androgenic activity, making it a selective treatment for these conditions. Explanation of Incorrect Options: (B) Phosphodiesterase Inhibitor: Incorrect. Phosphodiesterase (PDE) inhibitors, such as sildenafil and tadalafil, work by preventing the breakdown of cyclic GMP (cGMP), leading to smooth muscle relaxation and vasodilation. These drugs are mainly used for erectile dysfunction and pulmonary hypertension, but they do not influence DHT synthesis like finasteride does. (C) Alpha Blocker: Incorrect. Alpha-blockers like tamsulosin and doxazosin relax smooth muscle in the bladder neck and prostate, improving urine flow in patients with BPH. However, they do not reduce prostate size or affect DHT levels. In contrast, finasteride reduces prostate volume over time, providing long-term benefits in BPH. (D) Androgen Receptor Blocker: Incorrect. Androgen receptor blockers (e.g., flutamide, bicalutamide) prevent androgens from binding to their receptors, mainly used in prostate cancer treatment. Finasteride does not block androgen receptors but instead reduces the production of DHT, which is a major androgenic hormone.",
      "correct_choice_id": 210572,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40622521700320057/40622521700320057.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40622521700320057/40622521700320057.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51736,
      "choices": [
        {
          "id": 210576,
          "text": "Paclitaxel"
        },
        {
          "id": 210577,
          "text": "Vincristine"
        },
        {
          "id": 210578,
          "text": "Etoposide"
        },
        {
          "id": 210579,
          "text": "Irinotectan"
        }
      ],
      "text": "Microtubute formation is inhibited by :",
      "unique_key": "Q1886141",
      "question_audio": null,
      "question_video": null,
      "map_id": 34099797,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Vincristine, as it inhibits microtubule formation by binding to tubulin and preventing microtubule polymerization. Microtubules are essential for mitotic spindle formation during cell division, and their disruption leads to cell cycle arrest in metaphase. Vincristine belongs to the vinca alkaloid class of chemotherapy drugs, derived from the periwinkle plant (Catharanthus roseus). It is commonly used in the treatment of leukemias, lymphomas, and solid tumors. The major side effect of vincristine is neurotoxicity, which occurs due to its effects on microtubules in neurons, leading to peripheral neuropathy. Explanation of Incorrect Options: (A) Paclitaxel: Incorrect. Paclitaxel is a taxane that acts opposite to vincristine. Instead of inhibiting microtubule formation, paclitaxel stabilizes microtubules and prevents their depolymerization, leading to mitotic arrest and apoptosis. It is used in breast, ovarian, and lung cancer. (C) Etoposide: Incorrect. Etoposide is a topoisomerase II inhibitor, not a microtubule inhibitor. It works by preventing the re-ligation of DNA strands, leading to DNA damage and apoptosis. It is used in lung cancer, testicular cancer, and leukemias. (D) Irinotecan: Incorrect. Irinotecan is a topoisomerase I inhibitor, which prevents DNA unwinding and replication, leading to cell cycle arrest and apoptosis. It is mainly used in colorectal cancer and causes severe diarrhea as a major side effect.",
      "correct_choice_id": 210577,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56335461700320160/56335461700320160.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/56335461700320160/56335461700320160.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51737,
      "choices": [
        {
          "id": 210580,
          "text": "Nephrotoxicity"
        },
        {
          "id": 210581,
          "text": "Neutropenia"
        },
        {
          "id": 210582,
          "text": "Peripheral neuropathy"
        },
        {
          "id": 210583,
          "text": "Pulmonary fibrosis"
        }
      ],
      "text": "Which of the following is the most likely adverse response to occur as a result of the vincristine?",
      "unique_key": "Q5834707",
      "question_audio": null,
      "question_video": null,
      "map_id": 34515612,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Peripheral neuropathy, as vincristine is well known for causing neurotoxicity, particularly peripheral neuropathy. Vincristine is a vinca alkaloid that disrupts microtubule formation by binding to tubulin and inhibiting polymerization, leading to mitotic arrest and apoptosis. However, since microtubules are also crucial for axonal transport in neurons, vincristine’s toxicity predominantly affects the peripheral nervous system, resulting in sensory and motor neuropathy. Patients may experience paresthesias, loss of deep tendon reflexes, foot drop, wrist drop, and autonomic dysfunction (e.g., constipation, urinary retention). Vinblastine, another vinca alkaloid, is more myelosuppressive, while vincristine is more neurotoxic. Explanation of Incorrect Options: (A) Nephrotoxicity – Incorrect. Vincristine is not known for causing nephrotoxicity. Instead, drugs like cisplatin and methotrexate are more commonly associated with renal toxicity due to their accumulation in renal tubules. (B) Neutropenia – Incorrect. Unlike vinblastine, vincristine has less myelosuppressive effects, meaning significant neutropenia is uncommon. Other chemotherapy agents like paclitaxel, doxorubicin, and alkylating agents (cyclophosphamide, ifosfamide) are more commonly associated with neutropenia. (D) Pulmonary fibrosis – Incorrect. Pulmonary fibrosis is a hallmark toxicity of bleomycin and busulfan, not vincristine. Bleomycin causes oxidative damage to lung tissues, leading to restrictive lung disease and interstitial fibrosis.",
      "correct_choice_id": 210582,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19534821700320315/19534821700320315.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19534821700320315/19534821700320315.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51738,
      "choices": [
        {
          "id": 210584,
          "text": "Vincristine"
        },
        {
          "id": 210585,
          "text": "Cyclophosphamide"
        },
        {
          "id": 210586,
          "text": "Cytarabine"
        },
        {
          "id": 210587,
          "text": "Vinblastine"
        }
      ],
      "text": "Which anti-neoplastic drug is cell cycle non specific drug:",
      "unique_key": "Q5514699",
      "question_audio": null,
      "question_video": null,
      "map_id": 34563814,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Cyclophosphamide, as it is a cell cycle non-specific (CCNS) drug. Cyclophosphamide is an alkylating agent that works by cross-linking DNA strands, leading to DNA damage and apoptosis. Unlike cell cycle-specific (CCS) drugs, which act at particular phases of the cell cycle, alkylating agents like cyclophosphamide can exert their effects at any stage of the cell cycle, including the G0 phase. This makes them effective against both rapidly dividing and resting cancer cells, making them useful in a wide range of malignancies such as lymphomas, leukemias, breast cancer, and autoimmune conditions like lupus nephritis. Explanation of Incorrect Options: (A) Vincristine – Incorrect. Vincristine is a mitotic (M phase)-specific drug. It belongs to the vinca alkaloid class and inhibits microtubule polymerization by binding to tubulin, preventing spindle formation and leading to mitotic arrest. This makes it cell cycle-specific (CCS), affecting only cells in the M phase. (C) Cytarabine – Incorrect. Cytarabine (Ara-C) is an S-phase-specific drug. It is a pyrimidine analog that inhibits DNA polymerase, thereby blocking DNA replication. Since its activity is limited to the S phase, it is cell cycle-specific, primarily used in acute myeloid leukemia (AML) and other hematologic malignancies. (D) Vinblastine – Incorrect. Like vincristine, vinblastine is a vinca alkaloid that acts during the M phase by inhibiting microtubule formation, leading to mitotic arrest. It is cell cycle-specific, primarily used in Hodgkin’s lymphoma, testicular cancer, and Kaposi’s sarcoma.",
      "correct_choice_id": 210585,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19113121700320364/19113121700320364.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19113121700320364/19113121700320364.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51739,
      "choices": [
        {
          "id": 210588,
          "text": "leucovorin"
        },
        {
          "id": 210589,
          "text": "Amifostine"
        },
        {
          "id": 210590,
          "text": "Glucarpidase"
        },
        {
          "id": 210591,
          "text": "Adenosine"
        }
      ],
      "text": "A patient of CKD suffering from osteosarcoma was prescribed to use methotrexate in high dose. After taking few dose of chemotherapy agent ,patient start developing symptoms of drug toxicity and has been prescribed an antidote to immediately neutralise the effect of methotrexate. Which drug is most suitable for above complication?",
      "unique_key": "Q8663996",
      "question_audio": null,
      "question_video": null,
      "map_id": 34365886,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Glucarpidase Explanation for the Correct Answer: Glucarpidase is the most suitable antidote for methotrexate toxicity in patients with chronic kidney disease (CKD). Methotrexate (MTX) is primarily excreted by the kidneys, and patients with CKD are at high risk of toxicity due to its accumulation. High-dose methotrexate (used in osteosarcoma) can lead to severe toxicity, including mucositis, myelosuppression, hepatotoxicity, nephrotoxicity, and neurotoxicity. Glucarpidase (carboxypeptidase G2) is an enzyme that rapidly hydrolyzes methotrexate into inactive metabolites, thereby bypassing renal clearance and preventing further toxicity. It is particularly useful in patients with renal impairment, where standard clearance mechanisms are compromised. Thus, in a CKD patient experiencing methotrexate toxicity, glucarpidase is the best choice for immediate neutralization of methotrexate. Explanation for the Incorrect Answers: (A) Leucovorin (Folinic Acid) Leucovorin is a folate analog used for methotrexate rescue therapy, primarily by replenishing reduced folate stores and protecting normal cells from methotrexate-induced toxicity. However, leucovorin does not actively remove methotrexate from the body, and its effectiveness is reduced when methotrexate levels are extremely high or renal clearance is impaired. It is not effective in cases of severe renal impairment where methotrexate has already accumulated, making glucarpidase a better option. (B) Amifostine Amifostine is a cytoprotective agent used primarily to reduce nephrotoxicity of cisplatin and xerostomia in head and neck radiation therapy. It does not neutralize methotrexate toxicity or enhance its elimination. It has no role in managing methotrexate overdose or toxicity. (D) Adenosine Adenosine is used for paroxysmal supraventricular tachycardia (PSVT) and other cardiac indications. It has no function in reversing methotrexate toxicity and is completely unrelated to methotrexate metabolism or clearance.",
      "correct_choice_id": 210590,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69295731700305851/69295731700305851.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69295731700305851/69295731700305851.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51740,
      "choices": [
        {
          "id": 210592,
          "text": "Etoposide"
        },
        {
          "id": 210593,
          "text": "Cisplatin"
        },
        {
          "id": 210594,
          "text": "Bleomycin"
        },
        {
          "id": 210595,
          "text": "Docetaxel"
        }
      ],
      "text": "A patient suffering from testicular cancer taken chemotherapy drugs. Now he started developing peripheral vasoconstriction and Raynaud’s phenomenon. Which of the following drug is responsible for this?",
      "unique_key": "Q5506874",
      "question_audio": null,
      "question_video": null,
      "map_id": 34572411,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Bleomycin Explanation for the Correct Answer: Bleomycin is the chemotherapeutic agent responsible for causing peripheral vasoconstriction and Raynaud’s phenomenon in patients receiving treatment for testicular cancer. Bleomycin is an antitumor antibiotic commonly used in the treatment of germ cell tumors, including testicular cancer. One of its major side effects is vascular toxicity, which can manifest as Raynaud’s phenomenon, endothelial dysfunction, and vasospasm. Raynaud’s phenomenon is characterized by episodic vasospasm of the extremities, leading to pallor, cyanosis, and pain in response to cold or stress. Bleomycin-induced endothelial damage leads to vasoconstriction and reduced blood flow, making it a well-documented cause of Raynaud’s phenomenon in cancer patients. This vascular toxicity is thought to be dose-dependent and more common in patients receiving combination chemotherapy with bleomycin. Thus, bleomycin is the most likely drug responsible for the patient's symptoms. Explanation for the Incorrect Answers: (A) Etoposide Etoposide is a topoisomerase II inhibitor used in testicular cancer treatment, but it is not associated with vasoconstriction or Raynaud’s phenomenon. Its major toxicities include myelosuppression, secondary leukemia, and alopecia. (B) Cisplatin Cisplatin is a platinum-based chemotherapy agent commonly used in testicular cancer. It is not a known cause of Raynaud’s phenomenon but is associated with nephrotoxicity, ototoxicity, and peripheral neuropathy. While cisplatin can cause neurotoxicity, it does not induce vasospasm or Raynaud’s phenomenon like bleomycin. (D) Docetaxel Docetaxel is a taxane used in various cancers, including breast, prostate, and lung cancer, but it is not a standard drug in testicular cancer treatment. It primarily causes myelosuppression, fluid retention, and peripheral neuropathy, but not vasoconstriction or Raynaud’s phenomenon.",
      "correct_choice_id": 210594,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25367401700305866/25367401700305866.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25367401700305866/25367401700305866.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51741,
      "choices": [
        {
          "id": 210596,
          "text": "Methotrexate"
        },
        {
          "id": 210597,
          "text": "Vincristine"
        },
        {
          "id": 210598,
          "text": "Mercaptopurine"
        },
        {
          "id": 210599,
          "text": "Doxorubicin"
        }
      ],
      "text": "A child who was diagnosed with ALL taken chemotherapy drugs for treatment of the same. Now child is presented to oncology OPD with impaired memory, learning, attention and leuko encephalopathy. Which of the following drug is responsible for the above complication?",
      "unique_key": "Q9788237",
      "question_audio": null,
      "question_video": null,
      "map_id": 34037126,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Methotrexate Explanation for the Correct Answer: Methotrexate is the chemotherapeutic agent responsible for the neurological complications seen in this child who was treated for Acute Lymphoblastic Leukemia (ALL). Methotrexate is a folate antagonist used in the treatment of ALL and other malignancies. It works by inhibiting dihydrofolate reductase (DHFR), thereby blocking DNA synthesis and cell replication. Central Nervous System (CNS) toxicity is a well-recognized adverse effect of methotrexate, particularly in children who receive intrathecal or high-dose systemic methotrexate as part of their ALL treatment. Methotrexate-induced neurotoxicity can manifest as: Acute toxicity – headache, dizziness, nausea, and seizures. Subacute toxicity – leukoencephalopathy, presenting as memory impairment, learning difficulties, attention deficits, and cognitive dysfunction. Chronic toxicity – progressive white matter damage, leading to irreversible neurocognitive deficits. Leukoencephalopathy occurs due to demyelination and damage to oligodendrocytes, leading to cognitive dysfunction, memory impairment, and learning disabilities. The risk of neurotoxicity is higher in children due to the developing brain being more vulnerable to methotrexate-induced damage. Thus, methotrexate is the most likely drug responsible for the child's cognitive and neurological symptoms. Explanation for the Incorrect Answers: (B) Vincristine Vincristine is a microtubule inhibitor used in ALL treatment, but its primary toxicity is peripheral neuropathy, not CNS toxicity. It can cause paresthesia, foot drop, and autonomic dysfunction, but it does not cause leukoencephalopathy or cognitive impairment. (C) Mercaptopurine Mercaptopurine is a purine analog used as maintenance therapy in ALL, but it primarily causes myelosuppression and hepatotoxicity. It does not cause significant CNS toxicity or leukoencephalopathy. (D) Doxorubicin Doxorubicin is an anthracycline chemotherapy agent known for its cardiotoxicity (dose-dependent dilated cardiomyopathy). While doxorubicin can lead to oxidative stress-related organ damage, it does not cause leukoencephalopathy or cognitive dysfunction.",
      "correct_choice_id": 210596,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45269521700305891/45269521700305891.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45269521700305891/45269521700305891.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51742,
      "choices": [
        {
          "id": 210600,
          "text": "Methotrexate"
        },
        {
          "id": 210601,
          "text": "Ifosfamide"
        },
        {
          "id": 210602,
          "text": "Mitomycin C"
        },
        {
          "id": 210603,
          "text": "Capecitabine"
        }
      ],
      "text": "A patient suffering from colon cancer has been put on chemotherapeutic therapy and complains of a tingling sensation in the palms and soles. On examination there is edema and tender, symmetrical erythema, which is most pronounced over the fat pads of the distal phalanges as shown in image. Which of the following drug is responsible for above complication ?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/3(155).jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1612015",
      "question_audio": null,
      "question_video": null,
      "map_id": 34020450,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Capecitabine Explanation for the Correct Answer: Capecitabine is the chemotherapeutic drug responsible for the patient’s symptoms, which are indicative of Hand-Foot Syndrome (HFS), also known as Palmar-Plantar Erythrodysesthesia (PPE). Capecitabine is an oral prodrug of 5-Fluorouracil (5-FU) used in the treatment of colon cancer, breast cancer, and other solid tumors. One of its dose-limiting toxicities is Hand-Foot Syndrome (HFS), which manifests as tingling, burning sensations, redness, swelling, tenderness, and peeling of the skin on the palms and soles. The pathophysiology of HFS involves drug accumulation in sweat glands and capillary leakage, leading to inflammation and skin damage in high-friction areas such as the palms and soles. Risk factors for developing HFS include higher doses, prolonged exposure, and continuous infusion regimens. Management involves dose reduction, supportive care with emollients, corticosteroids, pyridoxine (vitamin B6), and cooling measures to reduce inflammation. Thus, Capecitabine (D) is the most likely cause of the patient's symptoms. Explanation for the Incorrect Answers: (A) Methotrexate Methotrexate is a folate antagonist used in colon cancer, but its toxicity mainly affects the bone marrow (myelosuppression), gastrointestinal mucosa (stomatitis, diarrhea), and liver (hepatotoxicity). It does not cause Hand-Foot Syndrome (HFS). (B) Ifosfamide Ifosfamide is a nitrogen mustard alkylating agent used in sarcomas and some solid tumors. Its characteristic toxicities include hemorrhagic cystitis (due to acrolein metabolite), neurotoxicity (encephalopathy), and nephrotoxicity, but not HFS. (C) Mitomycin C Mitomycin C is an antitumor antibiotic used in gastrointestinal and bladder cancers. It is associated with pulmonary fibrosis, nephrotoxicity, and hemolytic uremic syndrome (HUS) rather than Hand-Foot Syndrome.",
      "correct_choice_id": 210603,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2508891700305905/2508891700305905.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2508891700305905/2508891700305905.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51743,
      "choices": [
        {
          "id": 210604,
          "text": "Collecting duct extravasation"
        },
        {
          "id": 210605,
          "text": "Crystallization in the renal tubules"
        },
        {
          "id": 210606,
          "text": "Distal tubular cell necrosis"
        },
        {
          "id": 210607,
          "text": "Glomerular necrosis"
        }
      ],
      "text": "A 40-year-old man has been diagnosed with nonseminomatous germ cell tumor of the testis further examination and investigations reveal bulky lymphadenopathy, patient undergoes orchiectomy followed by multiagent chemotherapy with high-dose methotrexate. His serum creatinine rises from 1.10 mg/dL at baseline to 3.50 mg/dL after 4 weeks of therapy. What is the most likely explanation for this finding?",
      "unique_key": "Q5234512",
      "question_audio": null,
      "question_video": null,
      "map_id": 34835497,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Crystallization in the renal tubules. Methotrexate (MTX)-induced nephrotoxicity is a well-known complication, particularly at high doses, as used in the treatment of nonseminomatous germ cell tumors. Methotrexate and its metabolites are poorly soluble in acidic urine, leading to precipitation in the renal tubules, causing crystallization and tubular obstruction. This results in acute kidney injury (AKI), reflected in the rise in serum creatinine from 1.10 mg/dL to 3.50 mg/dL over 4 weeks. Prevention strategies include: Urinary alkalinization (e.g., using sodium bicarbonate) to increase solubility. Aggressive IV hydration to enhance drug elimination. Leucovorin (folinic acid) rescue to mitigate toxic effects on normal cells. Explanation of Incorrect Options: (A) Collecting duct extravasation Incorrect because methotrexate does not cause direct collecting duct injury leading to extravasation. Collecting duct pathology is more commonly associated with papillary necrosis (e.g., analgesic nephropathy or sickle cell disease). (C) Distal tubular cell necrosis Incorrect because methotrexate mainly causes crystallization rather than direct cytotoxic effects on the distal tubules. Aminoglycosides, amphotericin B, and cisplatin are known causes of distal tubular necrosis, not methotrexate. (D) Glomerular necrosis Incorrect because methotrexate does not primarily affect the glomeruli. Glomerular necrosis is more common in severe immune-mediated conditions (e.g., glomerulonephritis, thrombotic microangiopathy due to hemolytic uremic syndrome or vasculitis).",
      "correct_choice_id": 210605,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76792641700305934/76792641700305934.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76792641700305934/76792641700305934.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51744,
      "choices": [
        {
          "id": 210608,
          "text": "Doxorubicin"
        },
        {
          "id": 210609,
          "text": "Paclitaxel"
        },
        {
          "id": 210610,
          "text": "Methotrexate"
        },
        {
          "id": 210611,
          "text": "Cyclophosphamide"
        }
      ],
      "text": "Which of the following anticancer drugs works by inhibiting microtubule formation?",
      "unique_key": "Q8623401",
      "question_audio": null,
      "question_video": null,
      "map_id": 34740299,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Paclitaxel. Paclitaxel is a microtubule inhibitor that belongs to the taxane class of anticancer drugs. It works by stabilizing microtubules and preventing their depolymerization, which disrupts the normal dynamics of the mitotic spindle, leading to cell cycle arrest in metaphase (M phase) and ultimately apoptosis. Because microtubules are essential for chromosome segregation during cell division, their inhibition effectively prevents cancer cells from proliferating. Paclitaxel is commonly used to treat breast cancer, ovarian cancer, and non-small cell lung cancer. Explanation of Incorrect Options: (A) Doxorubicin: Doxorubicin is an anthracycline that exerts its anticancer effects by intercalating into DNA, inhibiting topoisomerase II, and generating free radicals that cause DNA strand breaks. It does not affect microtubules but rather interferes with DNA replication and transcription. It is widely used in hematologic malignancies and solid tumors such as breast cancer and lymphomas. (C) Methotrexate: Methotrexate is an antimetabolite that inhibits dihydrofolate reductase (DHFR), leading to a depletion of tetrahydrofolate and subsequent inhibition of DNA synthesis. It primarily affects the S phase of the cell cycle. While it is effective against cancers such as leukemia, lymphoma, and choriocarcinoma, it does not disrupt microtubule formation. (D) Cyclophosphamide: Cyclophosphamide is an alkylating agent that works by cross-linking DNA strands, leading to impaired DNA replication and cell death. It is used in a variety of cancers, including lymphoma, breast cancer, and ovarian cancer. However, it does not affect microtubules or their function.",
      "correct_choice_id": 210609,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51745,
      "choices": [
        {
          "id": 210612,
          "text": "Etoposide"
        },
        {
          "id": 210613,
          "text": "Vincristine"
        },
        {
          "id": 210614,
          "text": "Cisplatin"
        },
        {
          "id": 210615,
          "text": "5-Fluorouracil"
        }
      ],
      "text": "Which of the following drugs is considered a topoisomerase II inhibitor?",
      "unique_key": "Q6371067",
      "question_audio": null,
      "question_video": null,
      "map_id": 34665706,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Etoposide. Etoposide is a topoisomerase II inhibitor that works by preventing the re-ligation of DNA strands after they have been cleaved by the enzyme. Topoisomerase II is responsible for relieving supercoiling stress in DNA by introducing transient double-strand breaks, allowing for proper DNA replication and transcription. By inhibiting this enzyme, etoposide leads to DNA strand breaks, chromosomal damage, and apoptosis of rapidly dividing cancer cells. Etoposide is commonly used to treat small cell lung cancer, testicular cancer, and certain types of lymphomas and leukemias. Explanation of Incorrect Options: (B) Vincristine: Vincristine is a microtubule inhibitor that belongs to the vinca alkaloid class. It works by binding to tubulin and preventing microtubule polymerization, leading to mitotic arrest in M phase and cell death. It does not target topoisomerase II. Vincristine is commonly used to treat hematologic malignancies (e.g., leukemias, lymphomas) and solid tumors. (C) Cisplatin: Cisplatin is a platinum-based alkylating agent that works by cross-linking DNA strands, leading to impaired DNA replication and cell death. It is not a topoisomerase II inhibitor but is widely used to treat testicular cancer, ovarian cancer, and lung cancer. (D) 5-Fluorouracil (5-FU): 5-Fluorouracil is an antimetabolite that inhibits thymidylate synthase, leading to a depletion of thymidine and disruption of DNA synthesis. It primarily affects the S phase of the cell cycle. It is used in the treatment of colorectal, breast, and other solid tumors, but it does not affect topoisomerase II.",
      "correct_choice_id": 210612,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51746,
      "choices": [
        {
          "id": 210616,
          "text": "Methotrexate"
        },
        {
          "id": 210617,
          "text": "Doxorubicin"
        },
        {
          "id": 210618,
          "text": "Cyclophosphamide"
        },
        {
          "id": 210619,
          "text": "Gemcitabine"
        }
      ],
      "text": "Which drug is known for its cardiotoxicity as a major side effect?",
      "unique_key": "Q6817784",
      "question_audio": null,
      "question_video": null,
      "map_id": 34703438,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Doxorubicin Explanation: Doxorubicin is an anthracycline antibiotic known for its potential to cause cardiotoxicity, which can lead to congestive heart failure and other cardiac complications. Methotrexate, cyclophosphamide, and gemcitabine also have side effects, but cardiotoxicity is particularly associated with doxorubicin.",
      "correct_choice_id": 210617,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51747,
      "choices": [
        {
          "id": 210620,
          "text": "Methotrexate"
        },
        {
          "id": 210621,
          "text": "Paclitaxel"
        },
        {
          "id": 210622,
          "text": "Vincristine"
        },
        {
          "id": 210623,
          "text": "Doxorubicin"
        }
      ],
      "text": "A patient undergoing chemotherapy for breast cancer presents with signs of severe mucositis. Which of the following drugs is most likely associated with this side effect?",
      "unique_key": "Q7435582",
      "question_audio": null,
      "question_video": null,
      "map_id": 34088326,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) is the correct answer because it is strongly associated with mucositis, a common side effect of its mechanism of action. Methotrexate is an antimetabolite that inhibits dihydrofolate reductase (DHFR), leading to decreased synthesis of thymidine and purines, which are essential for DNA replication. Since rapidly dividing cells are most affected, tissues with high turnover rates—such as the oral and gastrointestinal mucosa—are particularly vulnerable, leading to severe mucositis (oral ulcers, inflammation, and pain). The severity of mucositis depends on the dose and duration of methotrexate therapy. Leucovorin (folinic acid) is often given as a rescue agent to reduce toxicity, especially in high-dose methotrexate regimens. Explanation of Incorrect Options: (B) Paclitaxel: Paclitaxel is a microtubule stabilizer used in breast cancer treatment, but it is not primarily associated with mucositis. Instead, its major side effects include peripheral neuropathy, myelosuppression, and hypersensitivity reactions. (C) Vincristine: Vincristine is a vinca alkaloid that disrupts microtubule formation, leading to cell cycle arrest in mitosis. While it is commonly associated with neurotoxicity (peripheral neuropathy, constipation, and autonomic dysfunction), it does not frequently cause severe mucositis. (D) Doxorubicin: Doxorubicin is an anthracycline that intercalates into DNA and inhibits topoisomerase II, leading to cardiotoxicity as a major side effect. While mild mucositis may occur, its most serious toxicities include dose-dependent cardiomyopathy and myelosuppression, making it less likely to be the cause of severe mucositis compared to methotrexate.",
      "correct_choice_id": 210620,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51748,
      "choices": [
        {
          "id": 210624,
          "text": "Leucovorin"
        },
        {
          "id": 210625,
          "text": "Carboplatin"
        },
        {
          "id": 210626,
          "text": "Etoposide"
        },
        {
          "id": 210627,
          "text": "Doxorubicin"
        }
      ],
      "text": "A 65-year-old patient with colorectal cancer is receiving 5-fluorouracil (5-FU) as part of their treatment regimen. Which of the following additional drugs is often combined with 5-FU to enhance its efficacy?",
      "unique_key": "Q1715561",
      "question_audio": null,
      "question_video": null,
      "map_id": 34965723,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) is the correct answer because it enhances the efficacy of 5-Fluorouracil (5-FU) by stabilizing its binding to thymidylate synthase, increasing its cytotoxic effects on cancer cells. 5-FU is an antimetabolite chemotherapy drug that gets converted into fluorodeoxyuridine monophosphate (FdUMP), which inhibits thymidylate synthase, an enzyme crucial for DNA synthesis. Leucovorin (folinic acid) potentiates this inhibition by increasing the stability of the FdUMP-thymidylate synthase complex, leading to enhanced cytotoxicity and better treatment outcomes in colorectal cancer. This combination is widely used in regimens like FOLFOX (5-FU, leucovorin, oxaliplatin) and FOLFIRI (5-FU, leucovorin, irinotecan) for colorectal cancer treatment. Explanation of Incorrect Options: (B) Carboplatin: Carboplatin is a platinum-based chemotherapy drug used primarily for ovarian, lung, and head and neck cancers. It works by forming DNA cross-links that inhibit replication, but it does not enhance the activity of 5-FU. It is not commonly used in standard colorectal cancer regimens. (C) Etoposide: Etoposide is a topoisomerase II inhibitor used in small cell lung cancer, testicular cancer, and lymphomas. It does not interact with the 5-FU pathway and is not a standard drug for colorectal cancer treatment. (D) Doxorubicin: Doxorubicin is an anthracycline chemotherapy agent that works by intercalating into DNA and inhibiting topoisomerase II. While effective in breast cancer, lymphoma, and sarcomas, it is not commonly used in colorectal cancer treatment or in combination with 5-FU.",
      "correct_choice_id": 210624,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    }
  ]
}